What is Catalog Technologies?
Catalog Technologies operates as a pioneer in the field of DNA digital storage, fundamentally reimagining how massive datasets are archived and retrieved. Unlike traditional silicon-based storage media, which face physical limitations regarding density and longevity, Catalog has developed a sophisticated platform that incorporates DNA into algorithmic workflows. This unique approach allows for the massive-scale encoding of digital information into synthetic DNA strands, offering a storage medium that is not only incredibly dense but also exceptionally durable. By integrating these biological components into standard data processing applications, the company provides a scalable solution for organizations grappling with the exponential growth of global data, positioning itself as a critical player in the future of information management and archival technology.
How much funding has Catalog Technologies raised?
Catalog Technologies has raised a total of $50M across 3 funding rounds:
Angel/Seed
$5M
Series A
$10M
Series B
$35M
Angel/Seed (2017): $5M with participation from New Enterprise Associates, Industry Ventures, Wilson Sonsini, IndieBio, Kauffman Fellows, SOSV, OS Fund, Starlight Ventures, StarVest Partners, and Pathbreaker Ventures
Series A (2020): $10M led by Horizons Ventures and Airbus Ventures
Series B (2021): $35M supported by Hanwha Impact
Key Investors in Catalog Technologies
New Enterprise Associates
Established in 1977 and headquartered in Menlo Park, California, New Enterprise Associates is a venture capital firm focused on helping entrepreneurs build businesses.
Horizons Ventures
Horizons Ventures focuses on investing in deep science and technology aimed at advancing humanity towards a significantly improved future.
IndieBio
IndieBio is a pioneering biotech program that provides bio-labs and pre-seed investment to scientists aiming to launch startups in deep tech and biotechnology.
What's next for Catalog Technologies?
With the successful completion of its latest financing round, Catalog Technologies is poised to accelerate the commercialization of its DNA storage platform. The strategic focus will likely shift toward scaling production capabilities and refining the integration of its encoding schemes into existing enterprise data centers. As the company moves deeper into its growth phase, the emphasis will remain on reducing the cost-per-bit of DNA synthesis and improving the speed of data retrieval, both of which are essential for widespread adoption. By continuing to attract high-caliber institutional backing, Catalog is well-positioned to define the standards for the next generation of archival storage, potentially rendering current magnetic and optical storage solutions obsolete for long-term data retention needs.
See full Catalog Technologies company page
